Starts in 5 days from now
LocationOnline
ProgrammesThe session, organised by CONNECT University (European Commission, DG CONNECT) will focus on some proposals for a EU digital strategy that strengthens its digital strategic autonomy, exploring its possible impacts in the EU’s Digital Decade Policy Programme.
Against a backdrop of rising geopolitical tensions and growing dependencies on foreign tech actors, the question of digital sovereignty has become increasingly urgent. Recent initiatives reflect a renewed ambition to strengthen Europe’s autonomy in strategic digital sectors, such as AI, semiconductors, cloud, and digital infrastructure. The session aims to exploresome of the proposals to ensure the EU works towards a digital strategy that strengthens its own digital strategic autonomy and their relevance to the EU’s Digital Decade Policy Programme.
This session is part of the broader Digital Decade Community activities and aims to foster a discussion around European digital sovereignty, ahead of the 2025 edition of the State of the Digital Decade Report.
For more information on the session and to join the session, please visit the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.